Dr. Rick Johnston is Founder and a Principal of Bioproduction Group. In this role, he manages Bio-G’s technical team and their engagement with some of the world’s largest biopharmaceutical organizations.
Dr. Johnston is an established expert in the field of biopharmaceutical operations and economics, and is regularly invited to speak at national and international conferences including recent engagements at Biopharmaceutical Process International (BPI), EuroBIO, Biopharmaceutical Manufacturing Development (BMD) Summit and Bioinnovation Leaders Summit where he has provided thought leadership in a number of areas including risk, uncertainty, simulation modeling, and analysis. He also regularly appears in trade journals such as Biopharm International, Bioprocess International and Pharma Focus Asia.
Dr. Johnston takes an active role in furthering education in biopharmaceutical operations. He is currently the Executive Director of the University of California at Berkeley’s CELDi Initative for Research in Biopharmaceutical Operations and an Adjunct Professor at the Keck Graduate Institute in Claremont, California. Dr. Johnston holds a Ph.D. in Industrial Engineering and Bioinformatics from the University of California at Berkeley, a Master of Science in Operations Research from Stanford University, and Bachelors’ degrees in Engineering and Liberal Arts from the University of Auckland, New Zealand.
David Zhang is Founder and a Principal of Bioproduction Group, leading Bio-G's operational team and their execution of projects delivering millions of dollars in savings to biopharmaceutical manufacturers.
David Zhang is considered an expert in biopharmaceutical process modeling, having lead the development of dozens of models covering nearly every aspect of biomanufacturing. His past experience includes work in cell culture (both batch-based and perfusion-based), batch and continuous recovery operations, disposables technologies, fill / finish and packaging operations, risk modeling, failure modes and effects analysis, de-bottlenecking, facility fit, process development and statistical analysis.
Mr. Zhang has also been extensively involved in healthcare economics outcomes research, providing robust statistical analysis to pharmaceutical companies in trial selection and drug screening.
Mr. Zhang brings a detailed technical understanding of statistics to Bioproduction Group, with a Bachelor's degree in Engineering Mathematics and Statistics from the University of California at Berkeley.
Quint King directs Bioproduction Group's Product Development group, responsible for building simple and elegant software to meet the complex needs of biomanufacturing operations.
Quint King is an expert in the field of product development, with over 22 years experience building desktop and enterprise software. He started his career in software development in the 1980s with 6502 assembly development of eprom debuggers and graphic software. He has since directed product development teams for three successful San Francisco-based startups, including Micrografx ABC FlowCharter, a leading Windows flowcharter in the early 1990s.
Mr. King's deep experience of the business and consumer market allows Bio-G to produce products that have the craftmanship and usability rarely found in enterprise software. He also brings a strong mathematics background to Bio-G with a Bachelor's degree in Operations Research from Cornell.